- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
- Report
- March 2024
- 194 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- August 2023
- 133 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Report
- July 2023
- 129 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- February 2021
- 420 Pages
United States
From €2305EUR$2,400USD£1,985GBP
- Report
- November 2022
- 100 Pages
Global
From €5715EUR$5,950USD£4,920GBP
- Report
- September 2019
- 40 Pages
Saudi Arabia
From €2492EUR$2,595USD£2,146GBP
- Report
- January 2021
- 136 Pages
China, Global
From €3000EUR$3,346USD£2,673GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Report
- September 2019
- 40 Pages
United States
From €2492EUR$2,595USD£2,146GBP
- Report
- September 2019
- 40 Pages
Russia
From €2492EUR$2,595USD£2,146GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2492EUR$2,595USD£2,146GBP
- Report
- September 2019
- 40 Pages
Germany
From €2492EUR$2,595USD£2,146GBP
- Report
- September 2019
- 40 Pages
France
From €2492EUR$2,595USD£2,146GBP
- Report
- May 2023
- 160 Pages
Global
From €5762EUR$5,999USD£4,961GBP
- Book
- February 2024
- 592 Pages
Sertraline is a type of antidepressant medication used to treat mental disorders such as depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder. It is a selective serotonin reuptake inhibitor (SSRI) and is one of the most commonly prescribed medications for mental health conditions. It works by increasing the amount of serotonin, a neurotransmitter, in the brain.
The sertraline market is highly competitive, with many pharmaceutical companies offering generic and branded versions of the drug. The market is expected to grow in the coming years due to the increasing prevalence of mental health disorders and the growing awareness of the importance of mental health.
Some of the companies in the sertraline market include Pfizer, GlaxoSmithKline, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more